Omron's SF2030 2nd Stage Strategic Plan
Analysis based on 8 articles · First reported Mar 11, 2026 · Last updated Mar 11, 2026
Omron's strategic plan, SF2030 2nd Stage, is expected to positively impact its stock price and market perception due to its focus on sustainable growth, data-driven transformation, and targeted investments in key regions like Europe and India. The emphasis on industrial automation and healthcare, coupled with structural reforms, signals a proactive approach to market challenges and opportunities.
Omron Corporation announced its medium-term roadmap, Shaping the Future 2030 (SF2030) 2nd Stage, outlining a strategic path to return to sustainable growth and transform into a data-driven 'GEMBA DX company'. The plan, covering the period through 2030, combines offensive investments in 13 focus businesses, including Controllers, Sensors, and Blood Pressure Monitors, with defensive structural reforms to rebuild the company's portfolio and strengthen execution capability. Omron aims to leverage its strengths in high-market-share devices, customer insights, and proprietary technology to provide data services. Europe is a focus region for Industrial Automation, targeting an +8.0% Revenue CAGR through FY2030, with specific initiatives in the United Kingdom, Italy, and Spain. India is identified as a key growth engine, targeting a +12.0% Revenue CAGR in Industrial Automation and 10% growth in Healthcare, supported by a 'Made in India' manufacturing structure. Junta Tsujinaga, President & CEO, emphasized 'Trusted Growth' and the transformation into a 'GEMBA DX company'.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard